开始
Elmind

XTLB uptrend to profitability

做多
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB)  
Elmind  
NASDAQ:XTLB   XTL Biopharmaceuticals Ltd.
Trend Analysis
0
0
trendanalysis
XTLB is going to consolidate a little at the current price before continuing on the up trend. We will buy once price pulls back to $3.02 or lower. Taking profits at various levels.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。